Sunshine Medical International

Cure is best with compassion.

A pharmaceutical company, with subsidiaries in Singapore, Thailand, and Uganda

Sunshine Medical is established in

  • Singapore

    Headquarters
  • Thailand

    Regional Hub
  • Uganda

    Regional Hub
About us

Trusted pharmaceutical trading, rooted in Singapore

Sunshine Medical is a pharmaceutical company which works on OSDs, Medical devices and Biologics through its partnering and co-development, co-ownership model. Sunshine also works with pharma customers to promote their products in Singapore, Thailand and Uganda directly and through Pharma distribution partners within APAC, EAC and other countries.

Sunshine Medical’s 100% subsidiary—Cell Differentiation Hub Pte. Ltd., Singapore and Cell Differentiation Hub Thailand Co. Ltd.—are working on Stem Cell, Cell Gene Therapy products and Plant based stem cells, Exosomes and relevant formulations. Sunshine promotes Cell Differentiation Hub’s products in several territories.

PPP

Private Public Partnerships

Sunshine Medical Uganda is working on setting up a Pharma Hub in Uganda, involving several interested pharma partners from India, Indonesia and China, covering OSD, Generic injectables, Liquid orals, Ointments and creams. Sunshine Medical Uganda is also exploring fill-finish units of Biologics and Vaccines within the same complex.

PPPs will have its own SPVs in Uganda with Sunshine Medical considering equity shareholding partnerships based on individual partners' contributions in technology, equipment, cash or cash equivalents, training and staffing, for example.

Our Team

The people behind Sunshine Medical

Experienced specialists across trading, regulatory affairs and science.

Sethu Ragupathy

Sethu Ragupathy

CTO, Director

Sethu is a graduate in Pharmaceutical Science and MBA, Pursuing his research in the area of Biologics. He has several years of Pharma experience. He and his team are working on several Plant-based exosome formulations.

Kawintra Siritharathikun

Kawintra Siritharathikun

Director, Thailand

Builds distribution and licensing partnerships, and opens new channels for partners entering the region.

Associate Professor Commander Sorayouth Chumnanvej, M.D., Ph.D.

Associate Professor Commander Sorayouth Chumnanvej, M.D., Ph.D.

Medical Advisor

Neurosurgeon at the Neurosurgery Unit, Surgery Department, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

Product categories

A portfolio built for modern healthcare

Browse each category to explore its subcategories.

Prescription medicines

Branded and generic therapies across the major clinical areas.

  • Antibiotics & anti-infectives
  • Cardiovascular
  • Diabetes & metabolic
  • Oncology
  • Respiratory

Generics

Trusted everyday remedies for pharmacies and retail channels.

  • Anti diabetics
  • Anti-retroviral
  • Antibiotics
  • Anti-cancer drugs
  • Speciality ophthalmic products

Medical devices & diagnostics

Precision equipment and tests for clinics, labs and hospitals.

  • Rapid diagnostic tests
  • Patient monitoring
  • Imaging consumables
  • Surgical instruments

Hospital & clinical supplies

Everyday consumables that keep care environments running.

  • Wound care
  • Infection control
  • IV & infusion
  • Protective equipment

Biologics, Cell & Gene Therapy Products

Temperature-sensitive products handled with full cold-chain care.

  • mAbs
  • Insulin R, N and 30:70
  • Insulin Glargine
  • Insulin Aspart
  • Darbepoetin
  • Liraglutide
  • Diabetic foot ulcer spray

Nutrition & wellness

Supplements and nutritional products for everyday health.

  • Liposomal formulated preparations
  • Exosome products
Research & development

Evidence first, from lab to shelf

We work alongside manufacturers and research institutes to evaluate, validate and bring forward products that meet the region's clinical needs.

Joint assets

Co-owned assets through Cell Differentiation Hub Pte. Ltd. and Cell Differentiation Hub (Thailand) Co., Ltd.

Joint research

Co-research products from pharma partners for Biologics—such as Insulin Aspart, and complex peptides.

Product evaluation

Independent assessment of efficacy, stability and quality before any product joins our portfolio.

Collaborative partnerships

Joint programmes with universities, hospitals and manufacturers to shape formulations for local needs.

Regulatory science

Dossier preparation and compliance research that speeds approvals across Thailand, Singapore and Malaysia.

  1. Identify

    Unmet clinical needs

  2. Evaluate

    Quality & efficacy review

  3. Validate

    Regulatory readiness

  4. Launch

    Market introduction

Business opportunities

Grow with us

Whether you manufacture, distribute or invest, there are several ways to work together.

Partner

Distribution

Appoint us as your regional distributor to reach hospitals and pharmacies in three markets.

Collaborate

Research and Development

We welcome you to join our co-research opportunities through our subsidiary, Cell Differentiation Hub.